Detalhe da pesquisa
1.
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Ann Intern Med
; 176(5): 658-666, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068272
2.
Incidence of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Illness in Infants in Low- and Middle-Income Regions During the Coronavirus Disease 2019 Pandemic.
Open Forum Infect Dis
; 10(12): ofad553, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38088983